– Nbc News
Needham Maintains Buy on G1 Therapeutics, Lowers Price Target to $18
Needham analyst Gil Blum maintains G1 Therapeutics (NASDAQ:GTHX) with a Buy and lowers the price target from $31 to $18.
President Biden Aides Find Second Batch Of Classified Documents At New Location
– Nbc News
Related Posts
Apple Investors Less Interested In AR/VR Headset Compared To This, Says Top Analyst Ahead Of WWDC 2023
As the countdown for Apple Inc.’s (NASDAQ:AAPL) annual WWDC begins, a renowned analyst stated that artificial intelligence is more important…
Industry Comparison: Evaluating Broadcom Against Competitors In Semiconductors & Semiconductor Equipment Industry
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors…
Eaton Raises FY23 Outlook After Solid Q1 Beat
Eaton Corp PLC (NYSE:ETN) first-quarter FY23 net sales jumped 13% year-over-year to $5.48 billion, +15% on an organic basis, beating…